
<style>
    * {
        box-sizing: border-box !important;
    }

    body {
        font-family: 'Inter', 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif !important;
        line-height: 1.9 !important;
        color: #1f1f1f !important;
        max-width: none !important;
        margin: 0 !important;
        padding: 8px 16px 16px 16px !important;
        background: #ffffff !important;
        font-size: 16.5px !important;
    }

    p {
        margin-bottom: 20px !important;
        font-size: 16.5px !important;
        line-height: 1.95 !important;
        color: #1f1f1f !important;
        font-weight: 400 !important;
    }

    strong, b {
        color: #1a73e8 !important;
        font-weight: 700 !important;
        background: rgba(26, 115, 232, 0.08) !important;
        padding: 2px 6px !important;
        border-radius: 8px !important;
    }

    /* Details/Summary (collapsible sections) */
    details {
        background: linear-gradient(135deg, #f8f9fa 0%, #ffffff 100%) !important;
        border-radius: 8px !important;
        padding: 24px 28px !important;
        margin: 24px 0 !important;
        border: none;
        box-shadow: none !important;
        transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1) !important;
    }

    details:hover {
        border-color: #1a73e8 !important;
        box-shadow: none !important;
        transform: translateY(-2px) !important;
    }

    details[open] {
        background: #ffffff !important;
        border-color: #1a73e8 !important;
        box-shadow: none !important;
    }

    summary {
        cursor: pointer !important;
        font-weight: 800 !important;
        color: #ffffff !important;
        font-size: 20px !important;
        padding: 16px 24px !important;
        border-radius: 8px !important;
        background: linear-gradient(135deg, #1a73e8 0%, #1557b0 100%) !important;
        transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1) !important;
        display: flex !important;
        align-items: center !important;
        user-select: none !important;
        box-shadow: none !important;
        letter-spacing: 0.5px !important;
    }

    summary:hover {
        background: linear-gradient(135deg, #1557b0 0%, #0d47a1 100%) !important;
        transform: translateX(6px) scale(1.02) !important;
        box-shadow: none !important;
    }

    summary:active {
        transform: translateX(4px) scale(0.99) !important;
    }

    summary::marker {
        color: rgba(255, 255, 255, 0.9) !important;
        font-size: 1.3em !important;
    }

    summary strong {
        background: rgba(255, 255, 255, 0.2) !important;
        color: #ffffff !important;
        padding: 4px 12px !important;
        border-radius: 8px !important;
        margin-left: 8px !important;
        font-size: 19px !important;
        letter-spacing: 1px !important;
    }

    /* Tables - Premium Design */
    table {
        width: 100% !important;
        border-collapse: separate !important;
        border-spacing: 0 !important;
        margin: 28px 0 !important;
        border-radius: 8px !important;
        overflow: hidden !important;
        box-shadow: none !important;
        border: none !important;
        background: #ffffff !important;
    }

    table.simple-table {
        background: linear-gradient(135deg, #ffffff 0%, #f8f9fa 100%) !important;
    }

    table tr {
        transition: all 0.25s cubic-bezier(0.4, 0, 0.2, 1) !important;
        position: relative !important;
    }

    table tr:nth-child(odd) {
        background: rgba(248, 249, 250, 0.5) !important;
    }

    table tr:nth-child(even) {
        background: rgba(255, 255, 255, 0.8) !important;
    }

    table tr:hover {
        background: linear-gradient(90deg, #e8f0fe 0%, #f1f8ff 100%) !important;
        transform: translateX(4px) scale(1.01) !important;
        box-shadow: none !important;
        z-index: 1 !important;
    }

    table td {
        padding: 18px 24px !important;
        border-bottom: 1px solid rgba(232, 234, 237, 0.6) !important;
        font-size: 16.5px !important;
        line-height: 1.7 !important;
        color: #1f1f1f !important;
        vertical-align: middle !important;
    }

    table tr:last-child td {
        border-bottom: none !important;
    }

    /* First column (A, B, C, D, E) */
    table td:first-child {
        font-weight: 800 !important;
        color: #ffffff !important;
        width: 52px !important;
        text-align: center !important;
        font-size: 18px !important;
        background: linear-gradient(135deg, #1a73e8 0%, #1557b0 100%) !important;
        border-right: 3px solid #1557b0 !important;
        position: relative !important;
        letter-spacing: 0.5px !important;
    }

    table tr:hover td:first-child {
        background: linear-gradient(135deg, #1557b0 0%, #0d47a1 100%) !important;
        box-shadow: none !important;
    }

    /* Second column (content) */
    table td:nth-child(2) {
        font-weight: 500 !important;
        padding-left: 28px !important;
    }

    /* Third column (empty - hide it) */
    table td:last-child:empty {
        display: none !important;
    }

    /* Lists */
    ul, ol {
        margin: 16px 0 !important;
        padding-left: 32px !important;
    }

    li {
        margin: 10px 0 !important;
        line-height: 1.8 !important;
        color: #1f1f1f !important;
    }

    ul.bulleted-list li {
        position: relative !important;
        padding-left: 8px !important;
    }

    ul.toggle {
        list-style: none !important;
        padding-left: 0 !important;
    }

    /* Links */
    a {
        color: #1a73e8 !important;
        text-decoration: none !important;
        font-weight: 600 !important;
        border-bottom: 2px solid transparent !important;
        transition: all 0.2s !important;
    }

    a:hover {
        border-bottom-color: #1a73e8 !important;
        background: rgba(26,115,232,0.08) !important;
        padding: 2px 4px !important;
        border-radius: 8px !important;
    }

    /* Images & Media */
    img, video {
        max-width: none !important;
        height: auto !important;
        border-radius: 8px !important;
        box-shadow: none !important;
        margin: 24px 0 !important;
        display: block !important;
        border: none !important;
    }

    img:hover, video:hover {
        box-shadow: none !important;
        border-color: #1a73e8 !important;
    }

    /* Code blocks (if any) */
    code {
        background: #f1f3f4 !important;
        padding: 2px 8px !important;
        border-radius: 8px !important;
        font-family: 'Courier New', monospace !important;
        font-size: 14px !important;
        color: #d93025 !important;
    }

    pre {
        background: #f8f9fa !important;
        padding: 8px 16px 16px 16px !important;
        border-radius: 8px !important;
        overflow-x: auto !important;
        border-left: 4px solid #1a73e8 !important;
    }

    /* Headings */
    h1, h2, h3, h4, h5, h6 {
        color: #1a73e8 !important;
        font-weight: 700 !important;
        margin-top: 24px !important;
        margin-bottom: 16px !important;
        line-height: 1.4 !important;
    }

    h1 { font-size: 32px !important; }
    h2 { font-size: 26px !important; }
    h3 { font-size: 22px !important; }
    h4 { font-size: 19px !important; }

    /* Blockquotes */
    blockquote {
        border-left: 4px solid #1a73e8 !important;
        padding-left: 20px !important;
        margin: 20px 0 !important;
        font-style: italic !important;
        color: #5f6368 !important;
        background: #f8f9fa !important;
        padding: 16px 20px !important;
        border-radius: 8px !important;
    }

    /* Horizontal Rule */
    hr {
        border: none !important;
        height: 2px !important;
        background: linear-gradient(to right, transparent, #1a73e8, transparent) !important;
        margin: 32px 0 !important;
    }

    /* Selection */
    ::selection {
        background: #e8f0fe !important;
        color: #1a73e8 !important;
    }

    /* Highlighter styles */
    .highlighted {
        background-color: #ffeb3b !important;
        transition: background-color 0.2s ease !important;
    }

    .highlighter-btn {
        background: none !important;
        border: none !important;
        cursor: pointer !important;
        font-size: 20px !important;
        padding: 0 8px !important;
        margin-left: 8px !important;
        transition: transform 0.2s ease !important;
        vertical-align: middle !important;
    }

    .highlighter-btn:hover {
        transform: scale(1.2) !important;
    }

    .highlighter-btn.active {
        transform: scale(1.1) !important;
        filter: brightness(1.2) !important;
    }

    .highlighter-mode-active {
        cursor: text !important;
    }


    /* Right padding to avoid overlap with sidebar buttons */
    body {
        padding-right: 50px !important;
    }

    @media (max-width: 768px) {
        body {
            padding-right: 16px !important;
        }
    }

</style>




<details open>
<summary><strong>15293</strong><button class="bionic-reading-btn" onclick="toggleBionicReading(event)" title="Toggle Bionic Reading (Ctrl+B)"><span id="bionicIcon">üëÅÔ∏è</span></button><button class="highlighter-btn" onclick="toggleHighlighter(event)" title="Toggle Highlighter (Ctrl+H)"><span id="highlighterIcon">üñäÔ∏è</span></button></summary>
<p class="" id="6718d91e-771a-46b0-8267-b5c610fb65b4">Researchers are studying
                                        various cellular processes in normal and diseased states to find new anticancer
                                        drug targets.  They develop a medication that inhibits an intracellular enzyme
                                        that converts adenosine to inosine.  With drug use, accumulation of enzyme
                                        substrates in the neoplastic cells leads to DNA strand breaks and subsequent
                                        apoptosis.  Which of the following malignancies is likely to be most responsive
                                        to this medication?</p>
<table class="simple-table" id="9f61d5af-b508-43fc-a346-1e6aaf4c0adc">
<tbody>
<tr id="49d075f8-f367-4010-9be9-9d0902a760fa">
<td class="" id="ADSA">A.</td>
<td class="" id="_Tkb">Hairy cell leukemia</td>
<td class="" id="Jwky"></td>
</tr>
<tr id="3a540171-c3fe-4376-a161-ce9d8db3913d">
<td class="" id="ADSA">B.</td>
<td class="" id="_Tkb">Malignant melanoma</td>
<td class="" id="Jwky"></td>
</tr>
<tr id="32c04304-644c-43f0-96bc-83fca13192b9">
<td class="" id="ADSA">C.</td>
<td class="" id="_Tkb">Ovarian teratoma</td>
<td class="" id="Jwky"></td>
</tr>
<tr id="296b25f5-3167-4e26-a87c-a4b2090bb7bc">
<td class="" id="ADSA">D.</td>
<td class="" id="_Tkb">Small cell lung cancer</td>
<td class="" id="Jwky"></td>
</tr>
<tr id="03e661cb-a16f-42b9-9b45-3d5289dfb5ed">
<td class="" id="ADSA">E.</td>
<td class="" id="_Tkb">Soft tissue sarcoma</td>
<td class="" id="Jwky"></td>
</tr>
</tbody>
</table>
<ul class="toggle" id="ef928340-ea5c-4fc9-b853-366806be95c6">
<li>
<details>
<summary>Submit</summary>
<table class="simple-table" id="cc4c1ae0-b05c-4bfb-8b13-17bb96807c36">
<tbody>
<tr id="6ab88a6a-d777-420e-92a1-d728e635fd65">
<td class="" id="vo&lt;a"><strong>A.</strong></td>
<td class="" id="m}oa"><strong>Hairy cell leukemia
                                                                    (52%)</strong></td>
<td class="" id="?&lt;Aq"></td>
</tr>
<tr id="bd55f6a8-ffec-4867-8003-c231ac33a705">
<td class="" id="vo&lt;a"><strong>B.</strong></td>
<td class="" id="m}oa"><strong>Malignant melanoma
                                                                    (20%)</strong></td>
<td class="" id="?&lt;Aq"></td>
</tr>
<tr id="66e78a35-9fc8-4d61-bb4a-5903f4c4139f">
<td class="" id="vo&lt;a"><strong>C.</strong></td>
<td class="" id="m}oa"><strong>Ovarian teratoma
                                                                    (6%)</strong></td>
<td class="" id="?&lt;Aq"></td>
</tr>
<tr id="9d900c3f-3e1f-4b5d-9226-a62a791846a6">
<td class="" id="vo&lt;a"><strong>D.</strong></td>
<td class="" id="m}oa"><strong>Small cell lung cancer
                                                                    (14%)</strong></td>
<td class="" id="?&lt;Aq"></td>
</tr>
<tr id="abd1ad7c-a41c-40b4-aa2b-a9f1e1a337df">
<td class="" id="vo&lt;a"><strong>E.</strong></td>
<td class="" id="m}oa"><strong>Soft tissue sarcoma
                                                                    (5%)</strong></td>
<td class="" id="?&lt;Aq"></td>
</tr>
</tbody>
</table>
<p class="" id="126fe98a-26cc-4693-b238-8332a838f556">
<strong>Incorrect</strong></p>
<p class="" id="19fe4a80-183f-47bb-bb7b-f21ffca0c2d9"><strong>Correct
                                                        answer A</strong></p>
<p class="" id="d0d79358-c9ee-4d70-9fd7-e74c5e077ac4">
<strong>52%Answered correctly</strong></p>
<p class="" id="74bfc259-bac5-4d2a-964f-01c3434c3714"><strong>35
                                                        secsTime Spent</strong></p>
<p class="" id="fd8c7252-74ea-42fa-9ac8-81a14d6ba5e0">
<strong>2024Version</strong></p>
<ul class="bulleted-list" id="8407391f-7903-4c23-82e5-86b925efc8eb">
<li style="list-style-type:disc"><strong>Explanation</strong></li>
</ul>
<ul class="bulleted-list" id="71af305a-497e-4920-83ae-c29bb3a87dd2">
<li style="list-style-type:disc"></li>
</ul>
<figure class="image" id="121a4f0e-772f-45a5-bf16-cb2216f93976"><a href="https://lh7-us.googleusercontent.com/WcJ7Ivkm9osXHZNnmgznf797vF-3OJ4JzWGKN4wynskUVOMTo-N8beAeBdGwWbBZqi7WS2LBVzJ0MMcvzTcurF8UdukRrHPB3-QNnqPB6kYNGCrwgR0lSgwRM3ivT0rgo19jnM8HqsmWYQSyou1l1m4"><img loading="lazy" src="https://lh7-us.googleusercontent.com/WcJ7Ivkm9osXHZNnmgznf797vF-3OJ4JzWGKN4wynskUVOMTo-N8beAeBdGwWbBZqi7WS2LBVzJ0MMcvzTcurF8UdukRrHPB3-QNnqPB6kYNGCrwgR0lSgwRM3ivT0rgo19jnM8HqsmWYQSyou1l1m4" style="width:451px"/></a>
</figure>
<p class="" id="8203dd98-cd3e-4241-92da-e850f2f1f687"><strong>Adenosine
                                                        deaminase (ADA) is a highly conserved enzyme that plays a
                                                        crucial role in purine metabolism.  ADA removes the amino group
                                                        from adenosine/deoxyadenosine and replaces it with a keto group,
                                                        leading to the formation of inosine/deoxyinosine.  These
                                                        compounds are subsequently converted into nontoxic waste
                                                        products (hypoxanthine and uric acid) and are excreted.</strong>
</p>
<p class="" id="6c806346-443a-4f14-b4ec-09c7f66476ad"><strong>ADA
                                                        inhibition results in the metabolism of deoxyadenosine through
                                                        an alternate pathway, whereby it is phosphorylated into the
                                                        toxic metabolite deoxyadenosine triphosphate.  Elevated
                                                        intracellular levels of deoxyadenosine triphosphate activate the
                                                        caspase system and also inhibit ribonucleotide reductase from
                                                        converting ribonucleotides to deoxyribonucleotides, which
                                                        depletes cells of DNA precursors.  This ultimately results in
                                                        the inhibition of DNA synthesis/repair and subsequent
                                                        apoptosis.</strong></p>
<p class="" id="0b1b98ff-f9a2-4196-914e-6908ff78bcdd"><strong>Although
                                                        all human cells contain ADA, developing lymphocytes are among
                                                        the most mitotically active cells; the inhibition/absence of ADA
                                                        is highly lymphocytotoxic.  Therefore, ADA inhibitors (eg,
                                                        cladribine) can be used to treat lymphocyte-derived cancers such
                                                        as hairy cell leukemia.  Similarly, children born with mutations
                                                        to both ADA genes have dramatic B- and T-lymphocyte impairment,
                                                        leading to the most severe form of severe combined
                                                        immunodeficiency.</strong></p>
<p class="" id="ba6e89ed-ede9-42d5-83f8-ff83164f8492"><strong>(Choices
                                                        B, C, and E)  Malignant melanoma is an aggressive melanocyte
                                                        tumor that metastasizes early and is associated with high
                                                        mortality rates when diagnosed at an advanced stage.  Ovarian
                                                        teratoma is an ovarian germ cell tumor that can be benign
                                                        (mature) or malignant (immature).  Soft tissue sarcoma is a
                                                        mesenchymal tumor that tends to grow slowly over time.  These
                                                        tumors are not derived from lymphocyte cells and are not
                                                        generally responsive to ADA inhibition.</strong></p>
<p class="" id="0f91fa3c-cb98-4b7d-bb3f-2ef6e67c2d98"><strong>(Choice
                                                        D)  Small cell lung cancer is a fast-growing neuroendocrine
                                                        tumor that is most common in smokers.  Fast-growing tumors are
                                                        more likely to express elevated levels of ADA; however, ADA
                                                        inhibition is primarily cytotoxic to lymphocyte-derived tumors
                                                        and has not been shown to be of significant benefit to other
                                                        cancer types.</strong></p>
<p class="" id="ba0a5777-71f2-4e5e-bd40-fcda780951b4">
<strong>Educational objective:</strong></p>
<p class="" id="355cc3cd-37a4-433a-85cc-a34e85a5e2d1"><strong>Adenosine
                                                        deaminase (ADA) inhibition/absence is highly lymphocytotoxic. 
                                                        Medications that block ADA are used to treat lymphocyte-derived
                                                        cancers.  Inherited gene mutations in ADA lead to the autosomal
                                                        recessive disease of severe combined immunodeficiency.</strong>
</p>
<p class="" id="431b2515-aff6-4c21-832f-87a60ce4301b">
<strong>Immunology</strong></p>
<p class="" id="87b4f96f-1e51-4a34-815e-1e5a49deefe1">
<strong>Subject</strong></p>
<p class="" id="0869df85-8db2-4724-8234-bd4ef5b8832f"><strong>Allergy
                                                        &amp; Immunology</strong></p>
<p class="" id="b2e94acb-2f94-454b-8681-8b0f7020540e">
<strong>System</strong></p>
<p class="" id="10dff77b-e92f-4874-b271-5734bd51c17a"><strong>Severe
                                                        combined immunodeficiency disease</strong></p>
<p class="" id="ad5df36f-fbd7-4e37-85ef-2af4d2c17637">
<strong>Topic</strong></p>
<p class="" id="a1b654e4-ea8b-45af-9f63-7d0c600f4592"><strong>Copyright
                                                        ¬© UWorld. All rights reserved.</strong></p>
</details>
</li>
</ul>
</details>


















<style>
.bionic-reading-btn {
    display: inline-flex;
    align-items: center;
    justify-content: center;
    width: 40px;
    height: 40px;
    background: rgba(255, 255, 255, 0.2);
    border: 2px solid rgba(255, 255, 255, 0.3);
    border-radius: 8px;
    color: white;
    font-size: 20px;
    cursor: pointer;
    transition: all 0.3s;
    margin-left: auto;
    flex-shrink: 0;
}

.bionic-reading-btn:hover {
    background: rgba(255, 255, 255, 0.35);
    border-color: rgba(255, 255, 255, 0.5);
    transform: scale(1.1);
}

.bionic-reading-btn.active {
    background: rgba(52, 168, 83, 0.4);
    border-color: rgba(52, 168, 83, 0.6);
}

.bionic-reading-btn.active:hover {
    background: rgba(52, 168, 83, 0.5);
}

summary {
    display: flex !important;
    align-items: center !important;
    gap: 12px !important;
}

    /* Highlighter styles */
    .highlighted {
        background-color: #ffeb3b !important;
        transition: background-color 0.2s ease !important;
    }

    .highlighter-btn {
        background: none !important;
        border: none !important;
        cursor: pointer !important;
        font-size: 20px !important;
        padding: 0 8px !important;
        margin-left: 8px !important;
        transition: transform 0.2s ease !important;
        vertical-align: middle !important;
    }

    .highlighter-btn:hover {
        transform: scale(1.2) !important;
    }

    .highlighter-btn.active {
        transform: scale(1.1) !important;
        filter: brightness(1.2) !important;
    }

    .highlighter-mode-active {
        cursor: text !important;
    }


    /* Right padding to avoid overlap with sidebar buttons */
    body {
        padding-right: 50px !important;
    }

    @media (max-width: 768px) {
        body {
            padding-right: 16px !important;
        }
    }

</style>



<script>
let bionicEnabled = false;
const originalContent = {};

function toggleBionicReading(event) {
    if (event) {
        event.preventDefault();
        event.stopPropagation();
    }

    bionicEnabled = !bionicEnabled;
    const btn = document.querySelector('.bionic-reading-btn');
    const icon = document.getElementById('bionicIcon');

    if (bionicEnabled) {
        btn.classList.add('active');
        icon.textContent = '‚úÖ';
        applyBionicReading();
    } else {
        btn.classList.remove('active');
        icon.textContent = 'üëÅÔ∏è';
        restoreOriginalText();
    }
}

function applyBionicReading() {
    // Seleciona todos os elementos de texto, EXCETO summary e buttons
    const textElements = document.querySelectorAll('p:not(summary p):not(button p), td:not(summary td):not(button td), li:not(summary li):not(button li)');

    textElements.forEach((element, index) => {
        // Ignora elementos que cont√™m outros elementos complexos
        if (element.querySelector('p, td, li, h1, h2, h3, h4, h5, h6, button, summary')) {
            return;
        }

        // Ignora se o elemento est√° dentro de um summary ou button
        if (element.closest('summary') || element.closest('button') || element.closest('.bionic-reading-btn')) {
            return;
        }

        // Salva o conte√∫do original
        if (!originalContent[index]) {
            originalContent[index] = {
                element: element,
                html: element.innerHTML
            };
        }

        // Aplica Bionic Reading
        const bionicText = convertToBionic(element.textContent);
        element.innerHTML = bionicText;
    });
}

function restoreOriginalText() {
    // Restaura o conte√∫do original
    Object.values(originalContent).forEach(item => {
        item.element.innerHTML = item.html;
    });
}

function convertToBionic(text) {
    // Divide o texto em palavras, mantendo pontua√ß√£o
    const words = text.split(/(\s+|[.,;:!?()""''\-‚Äì‚Äî])/);

    const bionicWords = words.map(word => {
        // Ignora espa√ßos e pontua√ß√£o
        if (word.match(/^\s+$/) || word.match(/^[.,;:!?()""''\-‚Äì‚Äî]+$/)) {
            return word;
        }

        // Ignora palavras muito curtas (1-2 letras)
        if (word.length <= 2) {
            return word;
        }

        // Determina quantas letras deixar em negrito (metade da palavra, arredondado para cima)
        const boldLength = Math.ceil(word.length / 2);

        // Separa a parte em negrito da parte normal
        const boldPart = word.substring(0, boldLength);
        const normalPart = word.substring(boldLength);

        // Retorna com a primeira parte em negrito
        return `<strong style="font-weight: 700 !important; color: inherit !important; background: none !important; padding: 0 !important;">${boldPart}</strong>${normalPart}`;
    });

    return bionicWords.join('');
}

// Adiciona atalho de teclado (Ctrl+B ou Cmd+B)
document.addEventListener('keydown', function(e) {
    if ((e.ctrlKey || e.metaKey) && e.key === 'b') {
        e.preventDefault();
        toggleBionicReading();
    }
});
</script>

<script>
    let highlighterActive = false;
    let questionHighlights = {};

    // Get question ID from the first summary strong tag
    function getQuestionId() {
        const firstSummary = document.querySelector('summary strong');
        return firstSummary ? firstSummary.textContent.trim() : '1';
    }

    // Load highlights from localStorage
    function loadHighlights() {
        const questionId = getQuestionId();
        const stored = localStorage.getItem('highlights_' + questionId);
        if (stored) {
            questionHighlights = JSON.parse(stored);
            applyStoredHighlights();
        }
    }

    // Save highlights to localStorage
    function saveHighlights() {
        const questionId = getQuestionId();
        localStorage.setItem('highlights_' + questionId, JSON.stringify(questionHighlights));
    }

    // Apply stored highlights
    function applyStoredHighlights() {
        Object.keys(questionHighlights).forEach(key => {
            const element = document.querySelector(`[data-highlight-id="${key}"]`);
            if (element && questionHighlights[key]) {
                element.classList.add('highlighted');
            }
        });
    }

    // Toggle highlighter mode
    function toggleHighlighter(event) {
        event.stopPropagation();
        highlighterActive = !highlighterActive;

        const btn = event.target.closest('.highlighter-btn');
        const icon = btn.querySelector('#highlighterIcon');

        if (highlighterActive) {
            btn.classList.add('active');
            icon.textContent = 'üñçÔ∏è';
            document.body.classList.add('highlighter-mode-active');
        } else {
            btn.classList.remove('active');
            icon.textContent = 'üñäÔ∏è';
            document.body.classList.remove('highlighter-mode-active');
        }
    }

    // Clear all highlights for this question
    function clearHighlights() {
        const questionId = getQuestionId();
        questionHighlights = {};
        localStorage.removeItem('highlights_' + questionId);
        document.querySelectorAll('.highlighted').forEach(el => {
            el.classList.remove('highlighted');
        });
    }

    // Handle text selection and highlighting
    document.addEventListener('mouseup', function(e) {
        if (!highlighterActive) return;

        const selection = window.getSelection();
        if (!selection.toString().trim()) return;

        const range = selection.getRangeAt(0);
        const container = range.commonAncestorContainer;

        // Only highlight text in paragraphs, not in buttons or other elements
        const paragraph = container.nodeType === 3 ? container.parentElement : container;
        if (paragraph.tagName !== 'P' && paragraph.tagName !== 'LI' && paragraph.tagName !== 'TD') {
            return;
        }

        // Create highlight span
        const span = document.createElement('span');
        span.classList.add('highlighted');

        // Generate unique ID for this highlight
        const highlightId = 'hl-' + Date.now() + '-' + Math.random().toString(36).substr(2, 9);
        span.setAttribute('data-highlight-id', highlightId);

        try {
            range.surroundContents(span);
            questionHighlights[highlightId] = true;
            saveHighlights();
        } catch (e) {
            console.log('Could not highlight selection');
        }

        selection.removeAllRanges();
    });

    // Load highlights when page loads
    window.addEventListener('load', loadHighlights);

    // Keyboard shortcut: Ctrl+H to toggle highlighter
    document.addEventListener('keydown', function(e) {
        if (e.ctrlKey && e.key === 'h') {
            e.preventDefault();
            const btn = document.querySelector('.highlighter-btn');
            if (btn) {
                toggleHighlighter({target: btn, stopPropagation: () => {}});
            }
        }
        // Ctrl+Shift+H to clear all highlights
        if (e.ctrlKey && e.shiftKey && e.key === 'H') {
            e.preventDefault();
            if (confirm('Clear all highlights for this question?')) {
                clearHighlights();
            }
        }
    });
</script>
